ALPHA TEKNOVA, INC. Net Income
ALPHA TEKNOVA, INC. (TKNO) reported Net Income of -$3.17 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement
us-gaap:NetIncomeLoss · last filed 2026-08-06
- ALPHA TEKNOVA, INC. net income (loss) attributable to parent for the quarter ending 2026-06-30 was -$3.17M.
- ALPHA TEKNOVA, INC. net income (loss) attributable to parent for the quarter ending 2026-03-31 was -$4.55M.
- ALPHA TEKNOVA, INC. net income (loss) attributable to parent for the quarter ending 2025-12-31 was -$4.76M.
- ALPHA TEKNOVA, INC. net income (loss) attributable to parent for the quarter ending 2025-09-30 was -$4.29M.
- ALPHA TEKNOVA, INC. net income (loss) attributable to parent for fiscal 2025 was -$17.26M.
- ALPHA TEKNOVA, INC. net income (loss) attributable to parent for fiscal 2024 was -$26.75M.
- ALPHA TEKNOVA, INC. net income (loss) attributable to parent for fiscal 2023 was -$36.78M.
- ALPHA TEKNOVA, INC. net income (loss) attributable to parent for fiscal 2022 was -$47.47M.
| Period end | Net Income (Loss) Attributable to Parent 3 month | Net Income (Loss) Attributable to Parent 6 month | Net Income (Loss) Attributable to Parent 9 month | Net Income (Loss) Attributable to Parent 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$3.17M 10-Q · filed 2026-08-06 | -$7.72M 10-Q · filed 2026-08-06 | -$12.48M derived: sum of 3 quarters · filed 2026-08-06 | -$16.77M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$4.55M 10-Q · filed 2026-05-07 | -$9.31M derived: sum of 2 quarters · filed 2026-05-07 | -$13.60M derived: sum of 3 quarters · filed 2026-05-07 | -$17.17M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$4.76M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | -$9.04M derived: sum of 2 quarters · filed 2026-03-02 | -$12.61M derived: sum of 3 quarters · filed 2026-08-06 | -$17.26M 10-K · filed 2026-03-02 |
| 2025-09-30 | -$4.29M 10-Q · filed 2025-11-07 | -$7.86M derived: sum of 2 quarters · filed 2026-08-06 | -$12.50M 10-Q · filed 2025-11-07 | -$18.22M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$3.57M 10-Q · filed 2026-08-06 | -$8.21M 10-Q · filed 2026-08-06 | -$13.93M derived: sum of 3 quarters · filed 2026-08-06 | -$21.50M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$4.64M 10-Q · filed 2026-05-07 | -$10.36M derived: sum of 2 quarters · filed 2026-05-07 | -$17.93M derived: sum of 3 quarters · filed 2026-05-07 | -$23.29M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$5.72M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | -$13.28M derived: sum of 2 quarters · filed 2026-03-02 | -$18.65M derived: sum of 3 quarters · filed 2026-03-02 | -$26.75M 10-K · filed 2026-03-02 |
| 2024-09-30 | -$7.57M 10-Q · filed 2025-11-07 | -$12.93M derived: sum of 2 quarters · filed 2025-11-07 | -$21.03M 10-Q · filed 2025-11-07 | -$31.68M derived: sum of 4 quarters · filed 2025-11-07 |
| 2024-06-30 | -$5.36M 10-Q · filed 2025-08-08 | -$13.46M 10-Q · filed 2025-08-08 | -$24.12M derived: sum of 3 quarters · filed 2025-08-08 | -$34.27M derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | -$8.10M 10-Q · filed 2025-05-09 | -$18.75M derived: sum of 2 quarters · filed 2025-05-09 | -$28.91M derived: sum of 3 quarters · filed 2025-05-09 | -$36.06M derived: sum of 4 quarters · filed 2025-05-09 |
| 2023-12-31 | -$10.66M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | -$20.81M derived: sum of 2 quarters · filed 2025-03-07 | -$27.96M derived: sum of 3 quarters · filed 2025-03-07 | -$36.78M 10-K · filed 2025-03-07 |
| 2023-09-30 | -$10.15M 10-Q · filed 2024-11-08 | -$17.31M derived: sum of 2 quarters · filed 2024-11-08 | -$26.12M 10-Q · filed 2024-11-08 | -$39.42M derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | -$7.15M 10-Q · filed 2024-08-13 | -$15.97M 10-Q · filed 2024-08-13 | -$29.27M derived: sum of 3 quarters · filed 2024-08-13 | -$51.74M derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | -$8.82M 10-Q · filed 2024-05-13 | -$22.11M derived: sum of 2 quarters · filed 2024-05-13 | -$44.59M derived: sum of 3 quarters · filed 2024-05-13 | -$50.79M derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | -$13.29M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | -$35.77M derived: sum of 2 quarters · filed 2024-03-27 | -$41.97M derived: sum of 3 quarters · filed 2024-03-27 | -$47.47M 10-K · filed 2024-03-27 |
| 2022-09-30 | -$22.47M 10-Q · filed 2023-11-13 | -$28.68M derived: sum of 2 quarters · filed 2023-11-13 | -$34.17M 10-Q · filed 2023-11-13 | -$37.82M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | -$6.20M 10-Q · filed 2023-08-11 | -$11.70M 10-Q · filed 2023-08-11 | -$15.35M derived: sum of 3 quarters · filed 2023-08-11 | -$18.60M derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | -$5.50M 10-Q · filed 2023-05-11 | -$9.14M derived: sum of 2 quarters · filed 2023-05-11 | -$12.39M derived: sum of 3 quarters · filed 2023-05-11 | -$14.64M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | -$3.65M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$6.90M derived: sum of 2 quarters · filed 2023-03-30 | -$9.15M derived: sum of 3 quarters · filed 2023-03-30 | -$9.80M 10-K · filed 2023-03-30 |
| 2021-09-30 | -$3.25M 10-Q · filed 2022-11-14 | -$5.50M derived: sum of 2 quarters · filed 2022-11-14 | -$6.16M 10-Q · filed 2022-11-14 | -$5.58M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | -$2.25M 10-Q · filed 2022-08-11 | -$2.90M 10-Q · filed 2022-08-11 | -$2.33M derived: sum of 3 quarters · filed 2022-08-11 | -$795.00K derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | -$655.00K 10-Q · filed 2022-05-12 | -$78.00K derived: sum of 2 quarters · filed 2022-05-12 | $1.46M derived: sum of 3 quarters · filed 2022-05-12 | $1.97M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $577.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-18 | $2.11M derived: sum of 2 quarters · filed 2022-03-18 | $2.62M derived: sum of 3 quarters · filed 2022-03-18 | $3.57M 10-K · filed 2022-03-18 |
| 2020-09-30 | $1.53M 10-Q · filed 2021-11-12 | $2.04M derived: sum of 2 quarters · filed 2021-11-12 | $2.99M 10-Q · filed 2021-11-12 | |
| 2020-06-30 | $512.00K 10-Q · filed 2021-08-13 | $1.46M 10-Q · filed 2021-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |